Tag: review

EB612, a first-in-class long-acting PTH(1-34) oral peptide  for hypoparathyroidism, produced robust bioavailability and sustained increases in calcium across three preclinical models; IND is expected in late 2026

LAS VEGAS, June 16, 2026 (GLOBE NEWSWIRE) -- In an era where financial markets move rapidly due to technological innovation, instant access to information, and shifting global economic conditions, investors must navigate an increasingly complex environment. Investment professional Brian Ferdinand believes that maintaining a strategic mindset and disciplined approach is essential for achieving long-term success.

NINGBO, China, June 15, 2026 (GLOBE NEWSWIRE) -- PN Smart Energy Limited (“PN Smart” or the “Company”) (NASDAQ: PN), a global independent power provider (IPP) focused on the development of clean power stations, critical energy materials, and intelligent energy infrastructure, today announced its official name change of Skycorp Solar Group Limited to PN Smart Energy Limited effective June 12, 2026.

MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune Medicine has built a differentiated discovery platform powered by proprietary immune data and AI

Laguna Hills, CA, June 15, 2026 (GLOBE NEWSWIRE) -- Glitter Bug Gold Buyers announced that the company has achieved accreditation from the Better Business Bureau (BBB) and currently maintains an A+ rating. The accreditation recognizes the company's commitment to ethical business practices, transparency, customer service standards, and marketplace integrity as it continues serving precious metals sellers throughout Orange County.

NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) -- PAVS (NASDAQ:PAVS) (the "Company"), a consumer products and digital commerce solutions company, today announced that it has entered into a definitive agreement with certain institutional investors for a registered direct offering of an aggregate of 50,000,000 Class A ordinary shares (or pre-funded warrants to purchase Class A ordinary shares in lieu thereof) at a purchase price of $0.20 per share. The gross proceeds to the Company from the offering are expected to be approximately $10 million, before deducting offering expenses.